The National Human Rights Commission (NHRC) has taken suo motu cognizance of a media report that the Head, Anaesthesiology Department, AIIMS had written a letter to the Medical Superintendent of AIIMS alleging that due to poor quality of life saving drugs her husband suffered reaction from the two drugs provided by the Institute.
She had requested the Medical Superintendent to withdraw and stop purchase of such spurious life saving drugs for AIIMS in the interest of patients' safety.
The Commission has observed that the contents of the press report, if true, raise a serious issue of violation of human rights of the patients in general and AIIMS in particular. It has issued notices to the Director, AIIMS, Secretary, Union Ministry of Health and Family Planning, New Delhi calling for reports within four weeks.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app